AGIO R&D Expenses
Agios Pharmaceuticals Inc · R&D Expenses
AGIO R&D Expenses
Latest reported$352.75Mperiod ending
AGIO TTM R&D Expenses ($41.04M → $352.75M)
TTM R&D Expenses
High-resolution chart · PNG
AGIO r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 352,751,000 | |
| 342,678,000 | |
| 334,358,000 | |
| 330,378,000 | |
| 317,411,000 | |
| 302,538,000 | |
| 298,345,000 | |
| 291,621,000 | |
| 301,007,000 | |
| 292,286,999 | |
| 290,525,998 | |
| 282,923,998 | |
| 264,067,998 | |
| 269,211,999 | |
| 271,346,000 | |
| 273,959,000 | |
| 272,765,000 | |
| 260,190,000 | |
| 247,733,000 | |
| 272,378,000 | |
| 300,142,000 | |
| 331,402,000 | |
| 367,470,000 | |
| 377,976,000 | |
| 390,093,000 | |
| 406,565,000 | |
| 410,894,000 | |
| 398,455,000 | |
| 379,344,000 | |
| 358,685,000 | |
| 341,324,000 | |
| 324,731,000 | |
| 315,087,000 | |
| 308,173,000 | |
| 292,681,000 | |
| 280,143,000 | |
| 267,869,000 | |
| 238,857,000 | |
| 220,163,000 | |
| 192,418,000 | |
| 167,803,000 | |
| 153,422,000 | |
| 141,827,000 | |
| 139,757,000 | |
| 129,255,000 | |
| 115,408,000 | |
| 100,372,000 | |
| 80,788,000 | |
| 70,065,000 | |
| 60,447,000 | |
| 54,502,000 | |
| 50,448,000 | |
| 45,443,000 | |
| 42,948,000 | |
| 41,037,000 |